Hines OJ - Search Results

1

Blockade of the chemokine receptor CXCR2 inhibits pancreatic cancer cell-induced angiogenesis.

Wente MN, Keane MP, Burdick MD, Friess H, Büchler MW, Ceyhan GO, Reber HA, Strieter RM, Hines OJ. Wente MN, et al. Among authors: hines oj. Cancer Lett. 2006 Sep 28;241(2):221-7. doi: 10.1016/j.canlet.2005.10.041. Epub 2006 Feb 3. Cancer Lett. 2006. PMID: 16458421

2

Palliation for pancreatic cancer. Feasibility of laparoscopic cholecystojejunostomy and gastrojejunostomy in a porcine model.

Patel AG, McFadden DW, Hines OJ, Reber HA, Ashley SW. Patel AG, et al. Among authors: hines oj. Surg Endosc. 1996 Jun;10(6):639-43. doi: 10.1007/s004649900118. Surg Endosc. 1996. PMID: 8662403

3

Median pancreatectomy: do the risks justify the effort?

Hines OJ, Reber HA. Hines OJ, et al. J Am Coll Surg. 2000 Jun;190(6):715-6. doi: 10.1016/s1072-7515(00)00333-1. J Am Coll Surg. 2000. PMID: 10873008 No abstract available.

4

Animal models of exocrine pancreatic cancer.

Hotz HG, Hines OJ, Foitzik T, Reber HA. Hotz HG, et al. Among authors: hines oj. Int J Colorectal Dis. 2000 Jun;15(3):136-43. doi: 10.1007/s003840000229. Int J Colorectal Dis. 2000. PMID: 10954185 Review.

5

Primary duodenal adenocarcinoma: a 40-year experience.

Ryder NM, Ko CY, Hines OJ, Gloor B, Reber HA. Ryder NM, et al. Among authors: hines oj. Arch Surg. 2000 Sep;135(9):1070-4; discussion 1074-5. doi: 10.1001/archsurg.135.9.1070. Arch Surg. 2000. PMID: 10982512

6

Kupffer cell blockade reduces hepatic and systemic cytokine levels and lung injury in hemorrhagic pancreatitis in rats.

Gloor B, Blinman TA, Rigberg DA, Todd KE, Lane JS, Hines OJ, Reber HA. Gloor B, et al. Among authors: hines oj. Pancreas. 2000 Nov;21(4):414-20. doi: 10.1097/00006676-200011000-00013. Pancreas. 2000. PMID: 11075997

7

G protein-coupled receptor signaling in human ductal pancreatic cancer cells: neurotensin responsiveness and mitogenic stimulation.

Ryder NM, Guha S, Hines OJ, Reber HA, Rozengurt E. Ryder NM, et al. Among authors: hines oj. J Cell Physiol. 2001 Jan;186(1):53-64. doi: 10.1002/1097-4652(200101)186:1<53::AID-JCP1004>3.0.CO;2-Q. J Cell Physiol. 2001. PMID: 11147814

8

An improved clinical model of orthotopic pancreatic cancer in immunocompetent Lewis rats.

Hotz HG, Reber HA, Hotz B, Foitzik T, Buhr HJ, Cortina G, Hines OJ. Hotz HG, et al. Among authors: hines oj. Pancreas. 2001 Mar;22(2):113-21. doi: 10.1097/00006676-200103000-00002. Pancreas. 2001. PMID: 11249064

9

Angiogenesis inhibitor TNP-470 reduces human pancreatic cancer growth.

Hotz HG, Reber HA, Hotz B, Sanghavi PC, Yu T, Foitzik T, Buhr HJ, Hines OJ. Hotz HG, et al. Among authors: hines oj. J Gastrointest Surg. 2001 Mar-Apr;5(2):131-8. doi: 10.1016/s1091-255x(01)80024-x. J Gastrointest Surg. 2001. PMID: 11331474

10

Therapy for pancreatic cancer with a recombinant humanized anti-HER2 antibody (herceptin).

Büchler P, Reber HA, Büchler MC, Roth MA, Büchler MW, Friess H, Isacoff WH, Hines OJ. Büchler P, et al. Among authors: hines oj. J Gastrointest Surg. 2001 Mar-Apr;5(2):139-46. doi: 10.1016/s1091-255x(01)80025-1. J Gastrointest Surg. 2001. PMID: 11331475

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

236 results

Search Page